Notification letter to non-registered shareholders and reply form
Filed with HKEX · Stock code 2335 · · 2 pages · English and Chinese
Pursuant to the amended Rules Governing The Listing of Securities on The Stock Exchange of Hong Kong Limited (the “ Listing Rules”) effective from 31 December 2023, the Company has adopted new arrangements to disseminate corporate communications (“Corporate Communications”) electronically. No printed copies of Corporate Communications will be mailed out to you except by request. Please note that b
Shaanxi Micot Pharmaceutical Technology Co., Ltd. on 6ix
Earlier from Shaanxi Micot Pharmaceutical Technology
- 2026 Interim report
- Announcement of allotment results
- List of directors and their roles and functions
- Documents on Display
Later from Shaanxi Micot Pharmaceutical Technology
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Proposed adoption of the h share incentive scheme and proposed general mandate to repurchase h shares
- Proposed general mandate to repurchase h shares and notice of extraordinary general meeting
- Notice of extraordinary general meeting
- Proxy form for the extraordinary general meeting to be held on 10 November 2026
Follow Shaanxi Micot Pharmaceutical Technology into a list and get an email when it puts out news.
Follow Shaanxi Micot Pharmaceutical Technology